By expenditures
| Name | Title | Type |
|---|---|---|
| Beth M Wewel | Chief Financial Officer | Auditee |
| Rachel Turek | Partner | Auditee |
| Jasmine Lammers | CFO | Auditee |
| Alan Post | CONTRACT CFO | Auditee |
| Michael A. Dierlam | Principal | Auditee |
| Beth Wewel | CHIEF FINANCIAL OFFICER | Auditee |
| Chris Tyhurst | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 373371 | 2024 | 2025-12-08 | CLIFTONLARSONALLEN LLP | $32.83M |
| 359692 | 2024 | 2025-06-24 | Bland and Associates PC | $35.47M |
| 311443 | 2023 | 2024-07-01 | Redw LLC | $27.99M |
| 310191 | 2023 | 2024-06-26 | Redw LLC | $27.90M |
| 16917 | 2022 | 2023-06-28 | Redw LLC | $41.25M |
| 52205 | 2022 | 2023-05-10 | Redw LLC | $34.46M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 373371 | 2024 | 2025-12-08 | 1163608 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163607 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163606 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163605 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163604 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163603 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163602 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163601 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163600 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163599 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163598 | 2024-003 | Material Weakness | Yes | N |
| 373371 | 2024 | 2025-12-08 | 1163597 | 2024-003 | Material Weakness | Yes | N |
| 311443 | 2023 | 2024-07-01 | 982271 | 2023-003 | Significant Deficiency | - | N |
| 311443 | 2023 | 2024-07-01 | 405829 | 2023-003 | Significant Deficiency | - | N |
| 310191 | 2023 | 2024-06-26 | 979499 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979498 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979497 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979496 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979495 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979494 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979493 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 979492 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403057 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403056 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403055 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403054 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403053 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403052 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403051 | 2023-001 | Significant Deficiency | - | L |
| 310191 | 2023 | 2024-06-26 | 403050 | 2023-001 | Significant Deficiency | - | L |